Metraipolis › archive › dc_c1eeffd85aed

Obinutuzumab in the treatment of idiopathic refractory membranous nephropathy: an observational case series — Europe PMC PMID:41756365

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41756365
DOI: 10.3389/fmed.2026.1704970
License (as archived): solo-consultazione
Archived: 2026-11-05T22:18:09.503Z
SHA-256 of the archived text: 012397a983229c50bfd66bf45c8a3327b19a032aeabd3d8037f9231d1e52d0b9
Stable URL of this page: https://metraipolis.com/documento/dc_c1eeffd85aed

How to cite

Obinutuzumab in the treatment of idiopathic refractory membranous nephropathy: an observational case series — Europe PMC PMID:41756365 — Europe PMC (en), https://europepmc.org/article/MED/41756365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c1eeffd85aed (Metraipolis archive dc_c1eeffd85aed, sha256 012397a983229c50bfd66bf45c8a3327b19a032aeabd3d8037f9231d1e52d0b9)

BibTeX

@misc{dcc1eeffd85aed,
  title = {Obinutuzumab in the treatment of idiopathic refractory membranous nephropathy: an observational case series — Europe PMC PMID:41756365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41756365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c1eeffd85aed; sha256 012397a983229c50bfd66bf45c8a3327b19a032aeabd3d8037f9231d1e52d0b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41756365. Agents can read the archived copy with the MCP tool read_document.